Author Topic: Pharmaceutical Sector  (Read 61270 times)

0 Members and 1 Guest are viewing this topic.

Offline rameez1

  • Junior Member
  • **
  • Posts: 131
  • Thanks Received: 0
    • View Profile
Re: Pharmaceutical Sector
« Reply #159 on: May 23, 2016, 01:03:01 PM »
Could anybody help me with finding a good Pakistan Pharma Sector report that speaks broadly about the forecasts, healthcare spending and future outlook of this sector. I have searched on google but to no avail, either the reports are too old or they are very company specific.

Thanks!

Pakinvestorsguide

Re: Pharmaceutical Sector
« Reply #159 on: May 23, 2016, 01:03:01 PM »

Offline MZ

  • Research
  • Senior Member
  • *****
  • Posts: 10142
  • Thanks Received: 33
    • View Profile
Re: Pharmaceutical Sector
« Reply #160 on: June 09, 2016, 04:32:09 PM »
Pakistan Pharmaceutical Sector
What’s in store for them?


? As per a new SOP published by DRAP, the Pharmaceutical companies will be allowed
to increase the prices of their drugs as was mandated by the Drug Pricing Policy 2015.
? To recall, the pricing policy allowed the prices of the scheduled drugs to be increased
upto 50% of CPI (with a cap of 4%), and the prices of non?scheduled drugs by up to
70% of CPI (with a cap of 6%).
? Moreover, reduction in customs duty of key raw materials from 5% to 3% in Budget’17
is also expected to yield favorable impact on the profitability of Pharma Sector.  
? GoP has also allocated PKR22.4bn for vertical healthcare programs in the Budget FY17
which is on top of the Prime Minister Healthcare program worth PKR9.0bn to provide
insurance cover for several ailments over the next 3 years.  
? Given a plethora of positive developments (particularly SEARL and FEROZ), we expect
the sector to remain in the limelight in the coming months.

BMA In Focus

Offline Shakir123

  • Junior Member
  • **
  • Posts: 440
  • Thanks Received: 0
    • View Profile
Re: Pharmaceutical Sector
« Reply #161 on: June 09, 2016, 04:58:16 PM »
Glaxo

Offline Arif Nadeem

  • Junior Member
  • **
  • Posts: 359
  • Thanks Received: 0
    • View Profile
Re: Pharmaceutical Sector
« Reply #162 on: June 21, 2016, 11:21:35 AM »
Pakistan Pharmaceutical Sector
What’s in store for them?


? As per a new SOP published by DRAP, the Pharmaceutical companies will be allowed
to increase the prices of their drugs as was mandated by the Drug Pricing Policy 2015.
? To recall, the pricing policy allowed the prices of the scheduled drugs to be increased
upto 50% of CPI (with a cap of 4%), and the prices of non?scheduled drugs by up to
70% of CPI (with a cap of 6%).
? Moreover, reduction in customs duty of key raw materials from 5% to 3% in Budget’17
is also expected to yield favorable impact on the profitability of Pharma Sector. 
? GoP has also allocated PKR22.4bn for vertical healthcare programs in the Budget FY17
which is on top of the Prime Minister Healthcare program worth PKR9.0bn to provide
insurance cover for several ailments over the next 3 years. 
? Given a plethora of positive developments (particularly SEARL and FEROZ), we expect
the sector to remain in the limelight in the coming months.

BMA In Focus
:dance :dance :dance :dance :dance :dance

Offline SMF-M

  • Junior Member
  • **
  • Posts: 401
  • Thanks Received: 0
    • View Profile
Re: Pharmaceutical Sector
« Reply #163 on: June 22, 2016, 06:24:18 PM »
NAB ACTION AGAINST DRUG BODY...!!!

NAB files corruption case against drug body members, pharmaceutical companies Over Rs1 bn scam

ISLAMABAD: The National Accountability Bureau Rawalpindi has filed a corruption case in the Accountability Court against top officials of Drugs Pricing Committee (DPC) for extended undue financial favours to pharma  companies/ firms in the shape of illegal and unjustified price increase to their drugs.

The NAB Rawalpindi filed the corruption reference against  Arshad Farooq Faheem (The then Chairman Drugs Pricing Committee) Additional Secretary (BPS-21), Wafaqi Mohtasib Secretariat , Dr. Muhammad Ali (The then Secretary cum Member Drugs Pricing Committee) ex-Member Pricing (BPS-21) DRAP, Saleem Isharat Hussain (The then Member Drugs Pricing Committee) Chief Drug Inspector (R), Health Department Government of Sindh,  Ayaz Ali Khan, The then Member Drugs Pricing Committee (Ex Chief Drugs Controller Punjab) Chief Operating Officer Pakistan Drugs Testing and Research Center, Lahore R/o 5-A, Faisal Town, Lahore, Sabir Ali (The then Member Drugs Pricing Committee) Chief Drug Inspector (R) Health Department, Govt Khyber Pakhtunkhwa, Abdul Salam Mufti (The then Member Drugs Pricing Committee) Chief Drug Inspector (R), Health Department Govt of Punjab, Sultan Ahmed (The then Member Drugs Pricing Committee) Senior Drug Inspector, Health Department Govt of Balochistan , Rashid Latif Sheikh (The then Member Drugs Pricing Committee) Ex-Director Cost Accounts Organisation, Ministry of Finance  and seven  pharmaceutical companies M/s Maple Pharmaceuticals (Pvt) Ltd,  M/s Akhai Agencies, M/s Zam Zam Corporation, Excel Health Care Laboratories (Pvt) Ltd, M/s Saffron Pharmaceutical (Pvt) Ltd, M/s Galaxy Pharma (Pvt) Ltd M/s Martin Dow Ltd and others regarding drug pricing issues in Accountability Court Islamabad.

The members of the DPC in connivance with each others and beneficiary Pharma companies / firms  extended undue financial favours to  Pharma  companies / firms in the shape of illegal and unjustified price increase to their drugs through DPC meeting held on 9-10-2012 & 22-01-2013 and subcommittee meeting held  on 19-11-2012.

The wrongful financial benefits derived by the eight pharmaceutical companies / firms on the basis of price increase through above said meetings comes to be Rs1078.08 million till 30-6-2015 (out of which one Pharma  company M/s RG Pharmaceutical (Pvt) Ltd returned  an amount of Rs385.12 million through plea bargain after deducting retailer and distributor margin.

This illegal benefit is perpetually being gained by the pharmaceutical companies / firms who submitted inflated invoices / incorrect / incomplete costing data and were selling of their drugs on prices which were illegally increased by the members of DPC.

As per details, NAB received a complaint wherein it was alleged that officers / officials of Ministry of National Regulation & Health Services Division (NR&HSD) and others were involved in illegal increase in prices of drugs through Drugs Pricing Committee meetings.

The prices of the drugs were fixed as per section 12 of Drugs Act 1976 by Drugs Pricing Committee (DPC) duly constituted by the Federal Govt.

During the process of investigation, it revealed that the pharmaceutical companies in connivance with accused officers/ officials submitted incomplete/incorrect and inflated invoices to DRAP for fixation of drugs prices at exorbitant rates.

Due to illegal price hike in the DPC meetings held on 9-10-2012 & 22-01-2013 and sub-committee meeting held on 19-11-2012 approximately Rs1078.08 million has been pocketed by these pharmaceutical companies causing unbearable burden on general public.

In this case two accused persons namely Tariq Haider and Mian M Khalid were arrested but released after payment of their liability through plea bargain.

So far NAB Rawalpindi recovered Rs385.11 million from accused persons namely Tariq Haider and Mian Khalid Mehmood Directors of M/S RG Pharmaceutical (Pvt) Ltd in the investigation against officers / officials of national regulations and services, beneficiaries and other regarding drug pricing issues through plea bargain whereas reference against accused persons for the remaining wrongful gain of Rs692.96 million has been filed in Accountability Court, Islamabad.

The NAB has recommended in this reference that the accused persons be punished in accordance with law and the drugs prices be reduced in the previous level so that general public may benefit from it as was done in the case of M/s RG Pharmaceutical Pvt Ltd.

Director General NAB Rawalpindi Zahir shah said NAB strongly believes in zero tolerance policy against corruption. NAB’s anti-corruption campaign is carried widely for awareness and prevention of corruption besides enforcement across the board. NAB hopes that joint efforts of all stakeholders can collaborate to check corruption and corrupt practices before happening with the help of all stakeholders.

He said the NAB officers/officials under the leadership of Chairman NAB Qamar Zaman Chaudary are determined and committed to perform their national duty with absolute objectivity, thorough professionalism, and unimpeachable integrity and without any leanings for or against anybody.
-- Faraz

Offline SMF-M

  • Junior Member
  • **
  • Posts: 401
  • Thanks Received: 0
    • View Profile
Re: Pharmaceutical Sector
« Reply #164 on: June 22, 2016, 06:25:58 PM »
This news came in morning, what will be impact?
-- Faraz

Offline AAMIR RAZA

  • Junior Member
  • **
  • Posts: 430
  • Thanks Received: 0
    • View Profile
Re: Pharmaceutical Sector
« Reply #165 on: June 22, 2016, 07:04:39 PM »


  Seniors Guide plz about it News? Positive/Negative impact?

Offline invincible

  • Senior Member
  • *****
  • Posts: 2775
  • Thanks Received: 13
    • View Profile
Re: Pharmaceutical Sector
« Reply #166 on: June 22, 2016, 09:25:22 PM »
Better to stay away from this sector for a while.

Offline invincible

  • Senior Member
  • *****
  • Posts: 2775
  • Thanks Received: 13
    • View Profile
Re: Pharmaceutical Sector
« Reply #167 on: July 05, 2016, 04:15:22 PM »
At current price level, which pharmaceutical company is more attractive n safe to invest in?

Thanx.

Offline afzalch

  • Senior Member
  • *****
  • Posts: 1143
  • Thanks Received: 0
    • View Profile
Re: Pharmaceutical Sector
« Reply #168 on: July 05, 2016, 10:50:25 PM »
At current price level, which pharmaceutical company is more attractive n safe to invest in?

Thanx.

Better to stay away from this sector for a while.
.         Bro invincible ,I think at present a lot of movement is going on in Searle and Highnoon, both are doing business well, profits are growing,payout history is bright, rest decision is your

Offline invincible

  • Senior Member
  • *****
  • Posts: 2775
  • Thanks Received: 13
    • View Profile
Re: Pharmaceutical Sector
« Reply #169 on: July 06, 2016, 03:33:44 AM »
At current price level, which pharmaceutical company is more attractive n safe to invest in?

Thanx.

Better to stay away from this sector for a while.
.         Bro invincible ,I think at present a lot of movement is going on in Searle and Highnoon, both are doing business well, profits are growing,payout history is bright, rest decision is your
 

:thanks:

What's ur take on Feroz?
Regards,

Offline Shakir123

  • Junior Member
  • **
  • Posts: 440
  • Thanks Received: 0
    • View Profile
Re: Pharmaceutical Sector
« Reply #170 on: July 06, 2016, 07:29:24 AM »
Glaxo

Offline engrusama

  • Active Member
  • ***
  • Posts: 607
  • Thanks Received: 5
    • View Profile
Re: Pharmaceutical Sector
« Reply #171 on: July 06, 2016, 08:54:22 PM »
At current price level, which pharmaceutical company is more attractive n safe to invest in?

Thanx.

Better to stay away from this sector for a while.
.         Bro invincible ,I think at present a lot of movement is going on in Searle and Highnoon, both are doing business well, profits are growing,payout history is bright, rest decision is your
 

:thanks:

What's ur take on Feroz?
Regards,

I am not talking technically but as a pharma person, I would always choose Feroz over any other company. The simple reason being their proven record of bringing new blockbuster drugs and continously investing in their machinery etc. I recently visited their new factory that will start production in 2017. It will be, in my opinion, the best factory in Pakistan when it will come online.

Offline ak_share

  • New Member
  • *
  • Posts: 84
  • Thanks Received: 0
    • View Profile
Re: Pharmaceutical Sector
« Reply #172 on: August 04, 2016, 11:18:48 AM »
Pharmaceutical companies, distributors: Ministry proposes heavy penalties, punishments

August 04, 2016 RECORDER REPORT

Ministry of Health has proposed heavy penalties and punishments for pharmaceutical companies, distributors and retailers allegedly involved in overcharging, illegal price hike and other violations for which summary would be moved to the Prime Minister for approval. Senate Standing Committee on National Health Services was held in the chairmanship of Senator Sajjad Hussain Turi on Wednesday.

Secretary Health Mohammad Ayub Sheikh told the committee that the health ministry is suggesting putting in place legislation for medicine manufacturing companies, distributors and retailers on overcharging, and draft of sentences will be soon sent to Prime Minister for approval.

He said for illegal increase in prices of drugs, a fine of Rs 10 million to Rs 100 million on Manufactures along with three year imprisonment, on Distributors Rs 10 million fine and two year imprisonment whereas Rs 0.1 million to Rs 1 million fine on Retailers with one year imprisonment is being suggested. He said five drug manufacture companies have sent a letter to the ministry for increasing prices. After 15 days of written intimation, the companies will be bound to increase prices.

He maintained that the Regulatory Board had also directed to the companies to submit written intimation before increase in the prices of medicines. He warned if any company doesn't comply with those directives, action will be taken against that company. During the committee meeting, Chairman Committee Sajjad Hussain Turi said the citizens in the Federally Administered Tribal Areas are deprived of basic health facilities due to unavailability of the health reforms in FATA.

Turi said that in FATA a Specialist Surgeon is drawing 75 thousand rupees salary and a General Medical Officer is pocketing 50 thousand rupees. If SAFRON and the Federal Ministry of Health cannot bring reforms regarding Health then where should we go for these reforms, Turi lamented. Chairman Committee expressed displeasure over absence of Director Health of FATA Secretariat from the committee meeting and summoned Secretary Health of FATA Secretariat with recommendations and suggestions about health reforms in the next meeting.

He suggested that the price of cigarette should be hiked to such an extent that it becomes out of reach of the common man so that smoking could be eliminated, which is hazardous to health. He said this move will also adversely affect the GDP, labour and owners connected with this industry.

Offline SBM

  • Master Troll
  • Administrator
  • Senior Member
  • *****
  • Posts: 11774
  • Thanks Received: 100
  • Ouulman :)
    • View Profile
I hate waking up.

Offline rsuleman

  • Senior Member
  • *****
  • Posts: 1037
  • Thanks Received: 10
    • View Profile
Re: Pharmaceutical Sector
« Reply #174 on: August 09, 2016, 11:15:34 AM »
http://www.brecorder.com/br-research/999:all/6825:pharmaceutical-sector-rise-of-the-natives/?date=2016-08-08
"There are over a dozen under construction plants in Pakistan which will apply for a FDA license in the future."
Application of license to FDA? Is Pakistani pharmaceutical companies need the license for accreditation from FDA (US) for a plant?  Is it a authority in Pakistan with the name of FDA? What is the role of DRAP, then? Is obtaining a license from FDA (of Pakistan or US) a requirement for exports of medicine?
Am I missing something?
Funny thing, BR report shows zero comment, while they do not provide any facility for the readers to make a comment!
 

Keep an open mind to new ideas. But, ALWAYS do your own homework and use common sense to figure out what's best in your situation.

Offline rsuleman

  • Senior Member
  • *****
  • Posts: 1037
  • Thanks Received: 10
    • View Profile
Re: Pharmaceutical Sector
« Reply #175 on: August 09, 2016, 11:20:35 AM »
http://www.brecorder.com/br-research/999:all/6825:pharmaceutical-sector-rise-of-the-natives/?date=2016-08-08
"There are over a dozen under construction plants in Pakistan which will apply for a FDA license in the future."
Application of license to FDA? Is Pakistani pharmaceutical companies need the license for accreditation from FDA (US) for a plant?  Is it a authority in Pakistan with the name of FDA? What is the role of DRAP, then? Is obtaining a license from FDA (of Pakistan or US) a requirement for exports of medicine?
Am I missing something?
Funny thing, BR report shows zero comment, while they do not provide any facility for the readers to make a comment!
"Pfizer and Wyeth are on sale".
Has anybody got any update on the progress of such sale, if any?
Keep an open mind to new ideas. But, ALWAYS do your own homework and use common sense to figure out what's best in your situation.

Offline SBM

  • Master Troll
  • Administrator
  • Senior Member
  • *****
  • Posts: 11774
  • Thanks Received: 100
  • Ouulman :)
    • View Profile
Re: Pharmaceutical Sector
« Reply #176 on: August 09, 2016, 08:42:10 PM »
http://www.brecorder.com/br-research/999:all/6825:pharmaceutical-sector-rise-of-the-natives/?date=2016-08-08
"There are over a dozen under construction plants in Pakistan which will apply for a FDA license in the future."
Application of license to FDA? Is Pakistani pharmaceutical companies need the license for accreditation from FDA (US) for a plant?  Is it a authority in Pakistan with the name of FDA? What is the role of DRAP, then? Is obtaining a license from FDA (of Pakistan or US) a requirement for exports of medicine?
Am I missing something?
Funny thing, BR report shows zero comment, while they do not provide any facility for the readers to make a comment!
"Pfizer and Wyeth are on sale".
Has anybody got any update on the progress of such sale, if any?

wyeth is selling one of is consumer prodcuts
not sure if the whole comapny is on sale
no idea about pfizer
I hate waking up.

Offline engrusama

  • Active Member
  • ***
  • Posts: 607
  • Thanks Received: 5
    • View Profile
Re: Pharmaceutical Sector
« Reply #177 on: August 10, 2016, 12:49:56 AM »
http://www.brecorder.com/br-research/999:all/6825:pharmaceutical-sector-rise-of-the-natives/?date=2016-08-08
"There are over a dozen under construction plants in Pakistan which will apply for a FDA license in the future."
Application of license to FDA? Is Pakistani pharmaceutical companies need the license for accreditation from FDA (US) for a plant?  Is it a authority in Pakistan with the name of FDA? What is the role of DRAP, then? Is obtaining a license from FDA (of Pakistan or US) a requirement for exports of medicine?
Am I missing something?
Funny thing, BR report shows zero comment, while they do not provide any facility for the readers to make a comment!

FDA approval is needed to export to many of the developed nations. As of now, there are no FDA approved pharmas in Pak. There are many in India and one recently exported a batch from Bangladesh. DRAP approval allows you to manufacture and sell drugs in Pakistan only. For export, you need registration with that country or FDA in case of developed countries esp. USA (the biggest pharma market)

Offline rsuleman

  • Senior Member
  • *****
  • Posts: 1037
  • Thanks Received: 10
    • View Profile
Re: Pharmaceutical Sector
« Reply #178 on: August 10, 2016, 07:27:50 AM »
http://www.brecorder.com/br-research/999:all/6825:pharmaceutical-sector-rise-of-the-natives/?date=2016-08-08
"There are over a dozen under construction plants in Pakistan which will apply for a FDA license in the future."
Application of license to FDA? Is Pakistani pharmaceutical companies need the license for accreditation from FDA (US) for a plant?  Is it a authority in Pakistan with the name of FDA? What is the role of DRAP, then? Is obtaining a license from FDA (of Pakistan or US) a requirement for exports of medicine?
Am I missing something?
Funny thing, BR report shows zero comment, while they do not provide any facility for the readers to make a comment!

FDA approval is needed to export to many of the developed nations. As of now, there are no FDA approved pharmas in Pak. There are many in India and one recently exported a batch from Bangladesh. DRAP approval allows you to manufacture and sell drugs in Pakistan only. For export, you need registration with that country or FDA in case of developed countries esp. USA (the biggest pharma market)
:thanks:
Keep an open mind to new ideas. But, ALWAYS do your own homework and use common sense to figure out what's best in your situation.

Tags: